MedPath

Management of Post Dural Pucture Headache After Lower Limb Surgeries: Oral Prednisolone vs Oral Pregabalin

Not Applicable
Completed
Conditions
Analgesia
Interventions
Registration Number
NCT04662125
Lead Sponsor
Zagazig University
Brief Summary

The aim of this study is to compare between oral prednisolone and oral pregabalin in management of PDPH to detect effectiveness of the treatment in reducing severity of PDPH, total rescue analgesic consumption and adverse effects of prednisolone and pregabalin in patients undergoing lower limb surgery.

Detailed Description

1. To compare between oral prednisolone and oral pregabalin in reducing severity post-dural puncture headache after spinal anesthesia in patients undergoing lower limb surgeries.

2. To calculate total amount of postoperative analgesic requirement for 72 hours after the onset of the headache in all patient groups.

3. To detect any side effects of the study medications in all patient groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
    • Both gender.
  • Age: 18- 65 years old.
  • Body Mass Index 20-30 kg/m2
  • American Society of Anesthesiologist (ASA) physical status I - II.
  • Patients are diagnosed as PDPH according to criteria of International Headache Society (IHS) after lower limb surgeries .
Exclusion Criteria
    • Allergy to study drugs.
  • History of chronic headache and migraine.
  • History of cerebrovascular accidents and neurological disorders.
  • Systemic infection
  • History of uncontrolled DM or hepatic disease or pregnant female
  • Patient refusal or uncooperative patient.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
group Acaffeine, paracetamol tabletGroup A (conservative treatment): oral fluid intake, recumbent positioning, combination of paracetamol and caffeine tablet three times per day for three days (2 tablets of Panadol-Extra tablet, film coated, GlaxoSmithKline Consumer Healthcare Holdings (US) LLC were given every 8hours) and stool softener and to maintain blinding a tablet of vitamins was given twice per day for three days.
group Coral pregabalinGroup C (oral pregabalin): patients who received conservative treatment as control group together with oral tablet pregabalin 150 mg twice per day for three days.
group BOral prednisoloneGroup B (oral prednisolone): patients who received conservative treatment as control group together with oral tablet prednisolone 20 mg once daily plus one tablet of vitamins to maintain blinding for three days.
Primary Outcome Measures
NameTimeMethod
Headache intensityat 72 hours

modified Lybecker score :1: include patients with mild headache not affecting daily activity with no accompanying symptoms, and oral analgesics work effectively to relieve pain, grade 2: moderate headache that restricts daily activity and leaves the patient in bed for most of the day, injectable analgesia is required to relieve pain, and grade 3: Severe headache with associated symptoms, completely restrict daily activity, with patients kept bed bound for the whole day.

pain intensity of headacheat 72 hours

measured by Visual Analogue Scale (VAS) on 0-10 cm scale (0-1 no headache, 2-4 mild headache, 5-7 moderate headache and 8-10 sever headache)

Secondary Outcome Measures
NameTimeMethod
Associated symptoms of post dural puncture headachefor 72 hours

The number of participant who has symptoms of post dural pucture headache as nausea, vomiting, diplopia, dizziness and neck stiffness

Adverse effects of the study drugs e.g. sedation, blurred vision, sleepiness, and dizzinessfor 72 hours

In case of sedation, the level will be assessed by using Ramsay Sedation Score (1= anxious or agitated, 2= cooperative and oriented, 3= responds to commands only and 4= brisk response to light tap or loud auditory stimulus)

total dose of rescue analgesiafor 72 hours

total amount of ketorolac

Trial Locations

Locations (1)

faculty of medicine, Zagazig university

🇪🇬

Zagazig, Egypt

© Copyright 2025. All Rights Reserved by MedPath